0
0°ÇÀÇ Èı⺸±â½Å°æ¸ÁÀ» ÀÌ¿ëÇÑ ÆÐÅÏÀνĿ¡ ´ëÇÑ °íÂû ÀÚ·á ÀÔ´Ï´Ù.
Ãâó : http://www.aistudy.co.kr/paper/pdf/pattern_hwang.pdf
¹ÞÀº º°Á¡
0/ 5
0°³ ÀÇ º°Á¡
º°Á¡À» ¸Å°ÜÁÖ¼¼¿ä.
½ºÅ¸¹÷½º ±âÇÁƼÄÜÀ» µå¸³´Ï´Ù.
»ç¿ëÈı⠵î·Ï : ¸Å¿ù Ãßõ ½ºÅ¸¹÷½º À½·áÄíÆù
¹®¼¸®ºä µî·Ï : ÃÖ´ë 10,000¿ø Áö±Þ(À̺¥Æ® ±â°£ ÃÖ´ë 20,000¿ø)
ÀÚ°¡¸é¿ªÁúȯÀ» À¯µµÇÏ´Â ÆÐÅÏÀνļö¿ëüÀÇ À¯ÀüÀÚ º¯ÀÌ
.x xx ¡Ü ¡Ü ºÐ ÀÚ ¼¼ Æ÷ »ý ¹° ÇÐ ´º ½º ·¹ ÅÍ [ Âü°í¹®Çå ] x. Funabiki`` M. et al.`` (xxxx) Autoimmune disorders associated with gain of function of the intracellular sensor MDAx. Immunity xx`` xxx-xxx x. Rice`` G.I. et al.`` (xxxx) Gain of function mutations in IFIHx cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. xx`` xxx-xxx x. Trinchieri`` G. et al.`` (xxxx) Type I interferon: friend or foe? J. Exp. Med. xxx`` xxxxx
Â÷³» ÆÐÅÏÀÎ½Ä CCTV ¾Ë°í¸®Áò ±¸Çö¿¡ °üÇÑ ¿¬±¸
Â÷³» ÆÐÅÏÀÎ½Ä CCTV ¾Ë°í¸®Áò ±¸Çö¿¡ °üÇÑ ¿¬±¸ x. °úÁ¦°³¿ä °úÁ¦À¯Çü / ¿¬±¸Ã¥ÀÓÀÚ : ±âº»¿¬±¸°úÁ¦ / ¿©°´»ç¾÷º»ºÎ ±è¹ü½Â ¿¬±¸±â°£ : xxxx. x. xx. ~ xxxx. x. xx.(x°³¿ù) x. ¿¬±¸¸ñÀû ½Â¹«¿øÀÇ °ËÇ¥½Ã°£À» ÁÙ¿© Â÷³» ¼ºñ½º °³¼±(°í°´ÀÀ´ë, ¾È³»¹æ¼Û, Â÷³» ¹ß±Ç, Ư½Ç¼ºñ½º µî)¿¡ ÁýÁßÇÒ ¼ö ÀÖ´Â ±â¹Ý ¸¶·Ã ÇÊ¿ä À̸¦ À§ÇÏ¿© ÃֽŠIT±â¼ú(ÆÐÅÏÀÎ½Ä ±â¹Ý ¿µ»óó¸®)À» Ȱ¿ëÇÑ È¿À²Àû Â÷³» °ËÇ¥¾÷¹«¸¦ Áö¿øÇϱâ À§ÇÑ ½Ã½ºÅÛÀ» °³¹ßÇϰíÀÚ ÇÔ x. ¿¬±¸³»¿ë ¿¬±¸ µ¿Çâ ¹× »ç·Ê - ¿¬±¸ µ¿Çâ - ±¹³» »ç·Ê -
|